Cargando…
Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12
Uterine leiomyosarcomas (ULMSs) are aggressive smooth muscle tumors associated with poor clinical outcome. Despite previous cytogenetic and molecular studies, their molecular background has remained elusive. To examine somatic variation in ULMS, we performed exome sequencing on 19 tumors. Altogether...
Autores principales: | Mäkinen, Netta, Aavikko, Mervi, Heikkinen, Tuomas, Taipale, Minna, Taipale, Jussi, Koivisto-Korander, Riitta, Bützow, Ralf, Vahteristo, Pia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758603/ https://www.ncbi.nlm.nih.gov/pubmed/26891131 http://dx.doi.org/10.1371/journal.pgen.1005850 |
Ejemplares similares
-
Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors
por: Mäkinen, Netta, et al.
Publicado: (2017) -
MED12 mutations and fumarate hydratase inactivation in uterine adenomyomas
por: Heikkinen, Tuomas, et al.
Publicado: (2018) -
Mutation analysis of components of the Mediator kinase module in MED12 mutation-negative uterine leiomyomas
por: Mäkinen, N, et al.
Publicado: (2014) -
MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas
por: Kämpjärvi, Kati, et al.
Publicado: (2016) -
Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer
por: Kämpjärvi, K, et al.
Publicado: (2012)